TipRanks
Evgen Pharma PLC (DE:8EV)
FRANKFURT:8EV
Germany Market
8EV
Evgen Pharma
RESEARCH TOOLSreports

Evgen Pharma (8EV) Stock News & Sentiment

0 Followers
TheraCryf Sets Results Date as Lead Addiction Therapy Nears Clinical Readiness
Premium
Company Announcements
TheraCryf Sets Results Date as Lead Addiction Therapy Nears Clinical Readiness
9d ago
TheraCryf Wins Shareholder Backing for £1.05m Fundraise and Share Subdivision
Premium
Company Announcements
TheraCryf Wins Shareholder Backing for £1.05m Fundraise and Share Subdivision
15d ago
TheraCryf raises £1.05m to advance addiction drug towards Phase 1 trials
Premium
Company Announcements
TheraCryf raises £1.05m to advance addiction drug towards Phase 1 trials
1M ago
TheraCryf Reports Strong Toxicology Data and Manufacturing Progress for Lead Addiction Drug
Premium
Company Announcements
TheraCryf Reports Strong Toxicology Data and Manufacturing Progress for Lead Addiction Drug
4M ago
TheraCryf to Host Investor Webinar as Lead Addiction Drug Nears Clinical Stage
Premium
Company Announcements
TheraCryf to Host Investor Webinar as Lead Addiction Drug Nears Clinical Stage
5M ago
TheraCryf Hits Key Manufacturing Milestone for Lead Addiction Drug Ox-1
Premium
Company Announcements
TheraCryf Hits Key Manufacturing Milestone for Lead Addiction Drug Ox-1
5M ago
TheraCryf Files New Process Patent to Extend Exclusivity for Lead Addiction Drug
Premium
Company Announcements
TheraCryf Files New Process Patent to Extend Exclusivity for Lead Addiction Drug
5M ago
More DE:8EV News >

8EV News on the Web

TheraCryf Wins Shareholder Backing for £1.05m Fundraise and Share Subdivision
TipRanks News
Neutral
TheraCryf Hits Key Manufacturing Milestone for Lead Addiction Drug Ox-1
TipRanks News
Neutral
TheraCryf Files New Process Patent to Extend Exclusivity for Lead Addiction Drug
TipRanks News
Neutral
TheraCryf shares rise 23% after biotech rejects takeover approach for neuropsychiatry assets
Proactive Investors
Bullish
TheraCryf Rejects Bid for Lead Neuropsychiatry Assets, Backs In-House Growth Strategy
TipRanks News
Neutral
TheraCryf Advances Lead Addiction Drug to Final Preclinical Toxicology Milestone
TipRanks News
Neutral
TheraCryf Secures Final Major Ox‑1 Patent and Advances Addiction Drug Towards Clinical Stage
TipRanks News
Neutral
TheraCryf Director Increases Stake, Signaling Confidence in Strategic Direction
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:8EV’s Media Buzz Sentiment?
Currently, no data Available
What is DE:8EV’s weekly average amount of articles?
In an average week, 0.75 articles about DE:8EV are published.
    What is DE:8EV’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    CRLCharles River Labs
    RCKTRocket Pharmaceuticals
    MRNAModerna
    HITIHigh Tide
    ASNDAscendis Pharma
    Showing the stocks with the most bullish news sentiment over the past week